Related Experiment Video
Updated: May 11, 2026
Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Advances in the management of intracerebral hemorrhage
J B Kuramatsu1, H B Huttner, S Schwab
1Department of Neurology, University of Erlangen-Nuremberg, Schwabachanlage 6, 91054 Erlangen, Germany.
Insights
Intracerebral hemorrhage (ICH) is a severe stroke type with high mortality and dependency. Current treatments are limited, but novel strategies like blood pressure management and neuroprotection are under investigation.
Area of Science:
- Neurology
- Neurosurgery
- Critical Care Medicine
Background:
- Intracerebral hemorrhage (ICH) is a devastating stroke subtype, causing significant mortality and long-term disability.
- Despite increasing incidence, randomized controlled trials have failed to demonstrate improved clinical outcomes for ICH.
- Specialized care in neuro-intensive care units (NICUs) offers some benefit, highlighting the need for advanced interventions.
Purpose of the Study:
- To review current and emerging treatment strategies for intracerebral hemorrhage.
- To summarize novel approaches being investigated to improve clinical endpoints in ICH patients.
Main Methods:
- Literature review of randomized controlled trials and ongoing investigations in ICH treatment.
- Synthesis of data on advanced therapies including blood pressure management, hemostasis, surgical techniques, thrombolysis, and neuroprotection.
Main Results:
- No current randomized trials show improved clinical endpoints for ICH treatments.
- Specialized NICU care is beneficial for severely injured patients.
- Ongoing trials explore aggressive blood pressure lowering, hemostatic agents, operative strategies, intraventricular thrombolysis, neuroprotection, and edema therapies.
Conclusions:
- Intracerebral hemorrhage remains a critical condition with poor outcomes and limited effective treatments.
- Novel therapeutic strategies are under active investigation to address the unmet needs in ICH management.
- Future research focuses on aggressive interventions and targeted therapies to improve patient survival and functional recovery.
Abstract:
Intracerebral hemorrhage (ICH) is one of the most detrimental sub-types of stroke and accounts for 10-15% of all strokes Qureshi et al. (Lancet 373(9675):1632-1644, 2009). ICH has an incidence of 10-30 cases per 100,000 people/year which is increasing and expected to double by the year 2050 Qureshi et al. (N Engl J Med 344 (19):1450-1460, 2001). Mortality rates still remain poor (30-50%) and functional dependency after ICH is high (~75%) van Asch et al. (Lancet Neurol 9 (2):167-176, 2010). Up to now, all randomized controlled trials investigating treatment approaches in ICH have failed to document improvements on clinical endpoints Mayer et al. (N Engl J Med 358 (20):2127-2137, 2008); Brouwers and Goldstein (Neurotherapeutics 9 (1):87-98, 2012). Only a specialized treatment of severely injured patients at dedicated neuro intensive care units [NICU] has been shown to be beneficial Qureshi et al. (Lancet 373(9675):1632-1644, 2009); Suarez et al. (Crit Care Med 32 (11):2311-2317, 2004). Currently, ongoing trials are investigating aggressive blood pressure lowering, hemostatic therapies, different operative strategies, intraventricular thrombolysis as well as neuroprotective approaches, and brain edema therapies. This review will summarize advanced treatment strategies and novel approaches which are currently under investigation.
Related Concept Videos
01:17Hemorrhagic Stroke l: Introduction
01:29Hemorrhagic Stroke ll: Pathophysiology
01:29Venous Thrombosis III: Interprofessional Care